Literature DB >> 233694

Abnormalities of triiodothyronine binding to lymphocyte and fibroblast nuclei from a patient with peripheral tissue resistance to thyroid hormone action.

J Bernal, S Refetoff, L J DeGroot.   

Abstract

T3 binding to lymphocyte nuclei has been studied in normal individuals and in a patient (MaG) with peripheral resistance to thyroid hormone action. This syndrome is defined by the presence of hypothyroidism or euthyroidism with high plasma levels of thyroid hormone. T3 bound to a single set of binding sites in normal adult lymphocyte nuclei with a mean Ka of 8.9 +/- 7.1 x 109 M-1, and a capacity of 4.4 +/- 2.9 fmol/100 micrograms DNA. A single binding site was also disclosed in MaG's lymphocytes with a Ka of 0.43 x 109 M-1 and a capacity of 10.5 fmol/100 micrograms DNA. This low affinity was not due to the presence of high plasma T3 level in the patient, since administration of 100 micrograms T3 to normal adult volunteers induced the presence of two different binding sites. The mechanism responsible for this phenomenon is unknown. To binding was also studied using cultured fibroblasts which were incubated in serum-less medium before the binding experiments. One single binding site (Ka, 1.9 x 10(10) M-1, capacity, 12.9 fmol/100 micrograms DNA) was detected in normal fibroblast nuclei. In contrast, a curvilinear Scatchard plot was obtained when MaG's fibroblasts were used. This result could be compatible with the presence of either two different binding sites or negative cooperativity. In support of the latter possibility, Hill plots gave a number lower than unity. The results suggest that the syndrome of peripheral tissue resistance to thyroid hormone action due to a defect at the level of the nuclear receptor. The possible existence of similar syndromes due to an alteration at the level of a post-T3-binding mechanism is not eliminated.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 233694     DOI: 10.1210/jcem-47-6-1266

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

1.  Characterization of a thyroid hormone receptor expressed in human kidney and other tissues.

Authors:  A Nakai; S Seino; A Sakurai; I Szilak; G I Bell; L J DeGroot
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

Review 2.  The molecular basis of thyroid hormone action.

Authors:  L J DeGroot; A Nakai; A Sakurai; E Macchia
Journal:  J Endocrinol Invest       Date:  1989-12       Impact factor: 4.256

Review 3.  Euthyroid hyperthyroxinemia.

Authors:  R Rajatanavin; L E Braverman
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

4.  Thyroid hormone unresponsiveness in two siblings with intrauterine growth retardation exophthalmos.

Authors:  T Ohzeki; S Egi; M Egawa; K Hachimori
Journal:  Eur J Pediatr       Date:  1984-01       Impact factor: 3.183

5.  Familial inappropriate TSH secretion: evidence suggesting a dissociated pituitary resistance to T3 and T4.

Authors:  J L Vandalem; G Pirens; G Hennen
Journal:  J Endocrinol Invest       Date:  1981 Oct-Dec       Impact factor: 4.256

6.  Peripheral insensitivity to thyroid hormones in a euthyroid girl with goitre.

Authors:  J Mäenpää; K Liewendahl
Journal:  Arch Dis Child       Date:  1980-03       Impact factor: 3.791

7.  Evidence of specific nuclear binding sites for T3 in the mouse cultured fibroblast.

Authors:  A Brisson-Lougarre; S Jozan; C Blum
Journal:  J Endocrinol Invest       Date:  1979 Oct-Dec       Impact factor: 4.256

8.  Thyroid hormone receptors and stimulation of angiotensinogen production in HepG2 cells.

Authors:  I A Darby; J Bouhnik; E D Coezy; P Corvol
Journal:  In Vitro Cell Dev Biol       Date:  1991-01

9.  Regulation of glycosaminoglycan synthesis by thyroid hormone in vitro.

Authors:  T J Smith; Y Murata; A L Horwitz; L Philipson; S Refetoff
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

10.  Receptor-mediated uptake of 3,3',5-triiodo-L-thyronine by cultured fibroblasts.

Authors:  S Y Cheng; F R Maxfield; J Robbins; M C Willingham; I H Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.